Roundup linked to liver disease
SAN DIEGO, CA. — Research scientists from the University of California at San Diego made a startling discovery through their extensive research of the weed killer Roundup. The researchers concluded that glyphosate, the active ingredient in Roundup, may contribute to severe liver disease in humans. According to KUSI, the researchers from San Diego published their findings in the Journal of Clinical Gastroenterology and Hepatology. Reporters attempted to reach representatives who could speak on behalf of Monsanto, the manufacturer of Roundup, or the parent company of Monsanto, Bayer AG.
The study conducted at the University of California at San Diego examined liver disease in human specimens. The scientists analyzed urine samples from two populations. The first was a group of people living with fatty liver disease that did not occur from alcohol misuse. The second group have healthy liver functions. The study examined 93 people. The study’s subjects were 41 percent male and 42 percent Caucasian. Out of the 93 people, 35 percent identified as Hispanic or Latino. The results of the study proved that the amount of glyphosate in the urine of people with fatty liver disease, irrespective of their age, race, weight, or body mass index (BMI).
The researchers were driven by the question of whether exposure to glyphosate could account for the spike in liver disease rates in the U.S. over the last two decades. Scientists noted that tests involving animal specimens showed an increase in liver disease in animals exposed to glyphosate. The University of California at San Diego researchers cited the studies of animal specimens exposed to glyphosate. However, scientists never made a correlation between glyphosate exposure and liver disease until researchers completed this study.
Almost half of Monsanto’s profits are linked to the sale of weed killers since the mid-90s, which is the same time that liver disease in the U.S. started to climb.
